title: What is the third serological marker associated with immune-mediated necrotizing myopathy?
authors.affiliation: a Department of General Internal Medicine, Tazuke-Kofukai, Medical Research Institute , Kitano Hospital , Osaka , Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.affiliation: b Department of Neurology , Keio University School of Medicine , Tokyo , Japan.
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.affiliation: c National Center of Neurology and Psychiatry , Kodaira , Japan.
authors.forename: I
authors.initials: I
authors.lastname: Nishino
authors.affiliation: d Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences , Kanazawa University , Ishikawa , Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Hamaguchi
authors.affiliation: a Department of General Internal Medicine, Tazuke-Kofukai, Medical Research Institute , Kitano Hospital , Osaka , Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fujimoto
mesh_terms: D000074183:ATPases Associated with Diverse Cellular Activities / Q000276:immunology*; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D015551:Autoimmunity / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001706:Biopsy / Q000379:methods; D002352:Carrier Proteins / Q000276:immunology*; D004265:DNA Helicases / Q000276:immunology*; D005260:Female; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008931:Mitochondria, Muscle / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000276:immunology*; D018482:Muscle, Skeletal / Q000473:pathology*; D009135:Muscular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D009336:Necrosis; D011239:Prednisolone / Q000008:administration & dosage*; D015203:Reproducibility of Results; D012263:Ribonucleosides / Q000008:administration & dosage*; D012698:Serologic Tests; D018271:Signal Recognition Particle / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D024101:Mitochondrial Proteins; D012263:Ribonucleosides; D018271:Signal Recognition Particle; C010052:mizoribine; D011239:Prednisolone; C553220:HMGCR protein, human; D006903:Hydroxymethylglutaryl CoA Reductases; D000074183:ATPases Associated with Diverse Cellular Activities; D004265:DNA Helicases; C486549:RUVBL1 protein, human; C122079:RUVBL2 protein, human